Access Bio Inc

Access Bio Inc., a U.S.-based biotechnology firm, specializes in the research, development, and manufacturing of advanced in vitro rapid diagnostic tests, biosensors, and molecular diagnostic solutions. These offerings are designed primarily for the prompt identification and prevention of infectious diseases. The company's core technological expertise spans immunochemical, biochemical, and molecular in vitro diagnostics. Among its diverse product range are rapid diagnostic tests like CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM. Their biosensor line features the CareStart G6PD Biosensor, while their molecular diagnostics portfolio includes CareStart HPV and CareStart CAH.